NVS Stock Recent News

NVS LATEST HEADLINES

NVS Stock News Image - barrons.com

Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.

barrons.com 2025 Apr 22
NVS Stock News Image - zacks.com

NVS' first-quarter performance has likely benefited from strong growth in Kisqali, Kesimpta, Pluvicto, Leqvio, Scemblix and Fabhalta.

zacks.com 2025 Apr 21
NVS Stock News Image - fxempire.com

The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.

fxempire.com 2025 Apr 21
NVS Stock News Image - zacks.com

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Novartis (NVS) have what it takes?

zacks.com 2025 Apr 18
NVS Stock News Image - fool.com

Equities are down this year because of Donald Trump's trade policies. The 47th U.S. president decided to impose steep tariffs on imported goods from most countries, although he has since significantly rolled back -- or at least paused -- these plans.

fool.com 2025 Apr 17
NVS Stock News Image - youtube.com

President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporters Monday in the Oval Office.

youtube.com 2025 Apr 14
NVS Stock News Image - reuters.com

U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.

reuters.com 2025 Apr 14
NVS Stock News Image - zacks.com

AbbVie's, Rinvoq and AstraZeneca's and Novartis are included in this Analyst Blog.

zacks.com 2025 Apr 14
NVS Stock News Image - zacks.com

Novartis plans to expand its current manufacturing, research and technology presence in the United States following Trump's announcement of tariffs on pharmaceutical imports.

zacks.com 2025 Apr 11
NVS Stock News Image - cnbc.com

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC.  The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.

cnbc.com 2025 Apr 11
10 of 50